These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4007893)

  • 41. Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase.
    Misulis KE; Clinton ME; Dettbarn WD; Gupta RC
    Toxicol Appl Pharmacol; 1987 Jul; 89(3):391-8. PubMed ID: 3603567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
    Del Rio G; Procopio M; Bondi M; Marrama P; Menozzi R; Oleandri SE; Grottoli S; Maccario M; Velardo A; Ghigo E
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1111-4. PubMed ID: 9426377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of acute and repeated pyridostigmine bromide administration on response acquisition with immediate and delayed reinforcement.
    van Haaren F; De Jongh R; Hoy JB; Karlix JL; Schmidt CJ; Tebbett IR; Wielbo D
    Pharmacol Biochem Behav; 1999 Feb; 62(2):389-94. PubMed ID: 9972708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide.
    degli Uberti EC; Bondanelli M; Margutti A; Ambrosio MR; Valentini A; Campo M; Franceschetti P; Zatelli MC; Pansini R; Trasforini G
    Neuroendocrinology; 1996 Nov; 64(5):398-404. PubMed ID: 8930940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats.
    Bharadwaj M; Pope C; Davis M; Katz S; Cook C; Maxwell L
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):872-879. PubMed ID: 28440910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium channel blocker reverses anticholinesterase-induced myopathy.
    Meshul CK
    Brain Res; 1989 Sep; 497(1):142-8. PubMed ID: 2790449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxprenolol plus ethanol causes no central nervous system depression--a comparison with lorazepam plus ethanol.
    Aucamp AK; Weis OF; Müller FO; Gill CE; Malan J
    S Afr Med J; 1984 Sep; 66(12):445-6. PubMed ID: 6385309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant.
    El-Masry EM; Abou-Donia MB
    J Toxicol Environ Health A; 2006 May; 69(10):919-33. PubMed ID: 16728371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visual motor co-ordination and dynamic visual acuity.
    Borland RG; Nicholson AN
    Br J Clin Pharmacol; 1984; 18 Suppl 1(Suppl 1):69S-72S. PubMed ID: 6525331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central effects of repeated administration of atenolol and captopril in healthy volunteers.
    McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
    Eur J Clin Pharmacol; 1994; 46(1):23-8. PubMed ID: 8005182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Electrophysiologic analysis of the action of a series of anticholinesterase agents on the functional state of peripheral nerves and neuromuscular transmission in warm-blooded animals].
    Kovtun SD; Kokshareva NV
    Fiziol Zh (1978); 1980; 26(4):541-6. PubMed ID: 6249648
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans.
    Zimerman LI; Liberman A; Castro RR; Ribeiro JP; Nóbrega AC
    Braz J Med Biol Res; 2010 Feb; 43(2):211-6. PubMed ID: 20084332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyridostigmine enhances atrial tachyarrhythmias in aging spontaneously hypertensive rats.
    Sayin H; Scridon A; Oréa V; Chapuis B; Chevalier P; Barrès C; Julien C
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1084-91. PubMed ID: 26174159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of subacute pyridostigmine administration on mammalian skeletal muscle function.
    Adler M; Deshpande SS; Foster RE; Maxwell DM; Albuquerque EX
    J Appl Toxicol; 1992 Feb; 12(1):25-33. PubMed ID: 1564249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide.
    Castro RR; Serra SM; Nóbrega AC
    Arq Bras Cardiol; 2000 Sep; 75(3):205-13. PubMed ID: 11018806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cytotoxicity of anti-cholinesterase compounds].
    Ishikawa S
    Nippon Ganka Gakkai Zasshi; 1996 Oct; 100(10):771-2. PubMed ID: 8937099
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity.
    Haigh JR; Johnston SR; Peters BM; Doctor BP; Gordon RK; Adler M; Gall KJ; Deshpande SS
    Chem Biol Interact; 2005 Dec; 157-158():381-2. PubMed ID: 16429510
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of effects of anatoxin-a(s) and paraoxon, physostigmine and pyridostigmine on mouse brain cholinesterase activity.
    Cook WO; Beasley VR; Dahlem AM; Dellinger JA; Harlin KS; Carmichael WW
    Toxicon; 1988; 26(8):750-3. PubMed ID: 3188065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.